Long-term study of the efficacy and safety of OnabotulinumtoxinA for the prevention of chronic migraine: COMPEL study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Long-term study of the efficacy and safety of OnabotulinumtoxinA for the prevention of chronic migraine: COMPEL study

Published:2018-02-05 Issue:1 Volume:19 Page:
ISSN:1129-2369
Container-title:The Journal of Headache and Pain
language:en
Short-container-title:J Headache Pain

Author:

Blumenfeld Andrew M.,Stark Richard J.,Freeman Marshall C.,Orejudos Amelia,Manack Adams Aubrey

Funder

Allergan plc

Publisher

Springer Science and Business Media LLC

Subject

Anesthesiology and Pain Medicine,Neurology (clinical),General Medicine

Link

http://link.springer.com/article/10.1186/s10194-018-0840-8/fulltext.html

Reference33 articles.

1. Headache Classification Committee of the International Headache Society (2013) The international classification of headache disorders, 3rd edition (beta version). Cephalalgia 33:629–808. https://doi.org/10.1177/0333102413485658

2. Manack AN, Buse DC, Lipton RB (2011) Chronic migraine: epidemiology and disease burden. Curr Pain Headache Rep 15:70–78. https://doi.org/10.1007/s11916-010-0157-z

3. Natoli JL, Manack A, Dean B, Butler Q, Turkel CC, Stovner L, Lipton RB (2010) Global prevalence of chronic migraine: a systematic review. Cephalalgia 30:599–609. https://doi.org/10.1111/j.1468-2982.2009.01941.x

4. Blumenfeld AM, Varon SF, Wilcox TK, Buse DC, Kawata AK, Manack A, Goadsby PJ, Lipton RB (2011) Disability, HRQoL and resource use among chronic and episodic migraineurs: results from the International Burden of Migraine Study (IBMS). Cephalalgia 31:301–315. https://doi.org/10.1177/0333102410381145

5. Buse DC, Manack AN, Serrano D, Reed ML, Varon S, Turkel CC, Lipton RB (2012) Headache impact of chronic and episodic migraine: results from the American Migraine Prevalence and Prevention Study. Headache 52:3–17. https://doi.org/10.1111/j.1526-4610.2011.02046.x

Cited by 143 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. International Headache Society Global Practice Recommendations for Preventive Pharmacological Treatment of Migraine;Cephalalgia;2024-09

2. Insights from 25 years of onabotulinumtoxinA in migraine — mechanisms and management;Nature Reviews Neurology;2024-08-19

3. The safety and efficacy of onabotulinumtoxinA injections for children and adolescents with chronic migraine: A systematic review and meta‐analysis;Headache: The Journal of Head and Face Pain;2024-08-11

4. Management of orofacial pain starts with careful differentiation of odontogenic and non-odontogenic pain;Drugs & Therapy Perspectives;2024-07

5. Sustained benefits of onabotulinumtoxinA treatment in chronic migraine: An analysis of the pooled Phase 3 REsearch Evaluating Migraine Prophylaxis Therapy (PREEMPT) randomized controlled trials;Headache: The Journal of Head and Face Pain;2024-06-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3